Etesian Wealth Advisors Inc. lessened its position in JPMorgan Chase & Co. by 2.9% in the fourth quarter, Holdings Channel.com reports. The firm owned 13,377 shares of the financial services ...
Results of the phase 2b ETESIAN trial of AZD8233 showed that the drug was effective, reducing low-density lipoprotein cholesterol (LDL-C) levels by 73% from baseline, when given as a once-monthly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback